News|Videos|April 7, 2026
PBMs, Transparency and Fiduciary Responsibility
PBM reform is here. What do new transparency and fiduciary rules mean for the industry? Federal legislation, new state laws and proposed reforms are placing pharmacy benefit managers under growing scrutiny. Managed Healthcare Executive® partnered with Drug Topics® on a timely webinar, PBMs, Transparency and Fiduciary Responsibility, examining how emerging PBM transparency requirements, fiduciary responsibilities and policy reforms could reshape relationships among payers, pharmacies and PBMs. Watch the recorded discussion now to hear expert perspectives on the evolving regulatory landscape and what these policy changes may mean for managed care strategy and pharmacy benefit operations.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Zepbound Lowers Health Care Costs in Older Adults With Obesity
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Ixekizumab, Tirzepatide Maintains Efficacy in Psoriatic Disease
4
Measles Resurgence Exposes US Vaccine Policy Risks, Experts Warn
5


































